Apriem Advisors Abbott Laboratories Transaction History

Apriem Advisors

$849 Million
Q3 2024

A detailed history of Apriem Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Apriem Advisors holds 3,142 shares of ABT stock, worth $370,630. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,142

Previous 3,220 2.42%

Holding current value

$370,630

Previous $334,000 7.19%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $7,805 - $9,214	-78 Reduced 2.42%	3,142 $358,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $19,239 - $21,476	-191 Reduced 5.6%	3,220 $334,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $2.04 Million - $2.25 Million	-18,611 Reduced 84.51%	3,411 $387,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $18,759 - $22,963	208 Added 0.95%	22,022 $2.42 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $527,707 - $633,160	-5,524 Reduced 20.21%	21,814 $2.11 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $591,981 - $659,591	5,874 Added 27.37%	27,338 $2.98 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.73 Million - $2.04 Million	17,911 Added 504.11%	21,464 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.03%	3,553 $344,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $13,682 - $16,684	120 Added 3.5%	3,552 $420,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $1,155 - $1,414	10 Added 0.29%	3,432 $483,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 5.52%	3,422 $404,000
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $5,289 - $6,226	50 Added 1.4%	3,622 $420,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $20,461 - $24,107	188 Added 5.56%	3,572 $428,000
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $24,780 - $27,003	-236 Reduced 6.52%	3,384 $371,000
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $17,869 - $21,701	195 Added 5.69%	3,620 $394,000
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $30,704 - $39,298	401 Added 13.26%	3,425 $313,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $5,214 - $7,624	-83 Reduced 2.67%	3,024 $239,000
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $78 - $87	1 Added 0.03%	3,107 $270,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $59,661 - $64,691	-729 Reduced 19.01%	3,106 $260,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $14,867 - $17,340	204 Added 5.62%	3,835 $323,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $38,804 - $46,915	-586 Reduced 13.9%	3,631 $290,000
Q4 2018 Feb 19, 2019	BUY	$65.56 - $74.27 $10,555 - $11,957	161 Added 3.97%	4,217 $305,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $18,364 - $22,154	302 Added 8.04%	4,056 $298,000
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $3,094 - $3,499	55 Added 1.49%	3,754 $225,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $198,562 - $212,581	3,699	3,699 $211,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.

Account